BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:488@inflames.utu.fi
DTSTART;TZID=Europe/Helsinki:20260610T110000
DTEND;TZID=Europe/Helsinki:20260610T120000
DTSTAMP:20260512T125829Z
URL:https://inflames.utu.fi/events/inflames-flagship-seminar-by-visiting-p
 rofessor-andy-chan-evolving-drug-modalities-from-antibodies-to-in-vivo-cel
 l-programming-to-treat-autoimmune-diseases/
SUMMARY:InFLAMES Flagship seminar by Visiting Professor Andy Chan: Evolving
  drug modalities from antibodies to in vivo cell programming to treat auto
 immune diseases
DESCRIPTION:Welcome to a Scientific seminar by InFLAMES Visiting Professor 
 Andy Chan!\n\nSpeaker: Andy Chan\nTitle: Evolving drug modalities from ant
 ibodies to in vivo cell programming to treat autoimmune diseases\nTime: 10
  June 2026\, 11-12\nLocation: Arje Scheinin\, Dentalia\nHost: Professor of
  Practice Timo Veromaa\, InFLAMES Flagship\n\nCoffee and sandwiches will b
 e served before the seminar.\n\nBiography\n\nDr. Andrew Chan is a former S
 enior Vice President of Research-Biology at Genentech\, Inc where he overs
 aw biological research across all therapeutic areas including oncology\, i
 mmunology\, neuroscience\, infectious diseases and regenerative medicine. 
 He is a leader in biotherapeutics discovery and development and integrates
  lessons learned about disease pathogenesis and mechanisms of therapy.\n\n
 Chan’s research focuses on how our immune systems protect us against for
 eign pathogens and yet cause autoimmune and inflammatory diseases. Chan is
  also co-inventor of ocrelizumab (Ocrevus™)\, the first B-cell directed 
 therapy approved by the FDA for treatment of both relapsing and progressiv
 e forms of multiple sclerosis.
ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/andre
 w_chan.jpg
CATEGORIES:Events in English,Tapahtumat
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20260329T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR